Mutational Activation of BRAF Confers Sensitivity to Transforming Growth Factor Beta Inhibitors in Human Cancer Cells

Oncotarget - United States
doi 10.18632/oncotarget.13226
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

ECM1 Prevents Activation of Transforming Growth Factor Beta, Hepatic Stellate Cells, and Fibrogenesis in Mice

Gastroenterology
HepatologyGastroenterology
2019English

Transforming Growth Factor Beta (TGF-β) and Inflammation in Cancer

Cytokine and Growth Factor Reviews
GeneticsMolecular BiologyBiochemistryEndocrinologyAllergyImmunologyMetabolismDiabetes
2010English

Transforming Growth Factor Beta 1 Regulates Fibroblast Growth Factor 7 Expression in Schwann Cells

Ochsner Journal
Medicine
2019English

Relationship Between Tamoxifen-Induced Transforming Growth Factor Beta 1 Expression, Cytostasis and Apoptosis in Human Breast Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
1995English

Transforming Growth Factor Beta Regulation of Tumor Progression in Metastatic Cancer

2004English

Transforming Growth Factor Beta-1 Expression in Macrophages of Human Chronic Periapical Diseases

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2017English

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

iScience
Multidisciplinary
2019English

Transforming Growth Factor-Beta Stimulates Collagen VII Expression by Cutaneous Cells in Vitro

Journal of Cell Biology
MedicineCell Biology
1992English

Expression of Transforming Growth Factor Beta Is Elevated in Human and Experimental Diabetic Nephropathy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy